Vertical transmission rates for HIV in the British Isles: Estimates based on surveillance data

British Medical Journal

Volumn 319, Issue 7219, 1999, Pages 1227-1229

  Duong, Trinh ^a   Ades, A E ^a   Gibb, Diana M ^b   Tookey, Pat A ^a   Masters, Janet ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; OBSTETRICS; PEDIATRICS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; UNITED KINGDOM; VERTICAL TRANSMISSION;

EID: 0033530441     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7219.1227     Document Type: Article

References (16)

1. 1 Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
2. 2 International Perinatal HIV Group. Mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of fifteen prospective cohort studies. N Engl J Med 1999;340:977-87.
3. 3 European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353:1035-9.
4. 4 Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA 1998;280:55-60.
5. 5 Nicoll A, McGarrigle C, Brady T, Ades AE, Tookey PA, Duong T, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom; results from national surveillance 1988-1996. BMJ 1998;316:253-8.
6. 6 Dunn DT, Ades AE. Estimating the HIV vertical transmission rate and the pediatric AIDS incubation period from prospective data. J Am Stat Assor 1997;91:935-43.
7. 7 Gibb DM, Walters S. Guidelines for management of children with HIV infection. Horsham: AVERT, 1993:1-39.
8. 8 US Public Health Service recommendations for human immunodeficiency virus counselling and voluntary testing for pregnant women. MMWR 1995;44:1-14.
9. 9 Efron B, Tibsbirani J. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986;1:54-77.
10. 10 Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper U, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS 1998;12:205-10.
11. 11 Lindegren ML, Byers B, Roger M, Wortley P, Fleming P. On the verge of elimination of perinatally acquired HIV/AIDS? Updated trends in the United States. 6th conference on retroviruses and opportunistic infections Chicago 1999; Abstract 228.
12. 12 Fiscus S, Adimora AA, Schoenbach VJ, Wilfert C, Johnson VA. Can zidovudine monotherapy continue to reduce perinatal HIV transmission? The North Carolina experience 1993-1997. XII World AIDS Conference Geneva June 1998; Abstract 33162.
13. 13 Ciria LM. Impact of zidovudine on perinatal HIV transmission in Mallorca Island, Spain. XII World AIDS Conference Geneva June 1998; Abstract 23314.
14. 14 Galvaao NO, Silva CL, Naud PSV, Chaves EBM, Zachia SA, Larangeira M, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine (ZDV) treatment. XII World AIDS Conference Geneva June 1998; Abstract 12155.
15. 15 Rakusan TA, Temple V, Hart L, Loechelt B, Rana S, Young M, et al. Use of zidovudine to reduce the risk of perinatal transmission of HIV infection in the Washington metropolitan area. XII World AIDS Conference Geneva June 1998; Abstract 12157.
16. 16 Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998;12:F241-7.